Detalhe da pesquisa
1.
Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression.
N Engl J Med
; 389(14): 1298-1309, 2023 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37792613
2.
Novel and emerging treatments for major depression.
Lancet
; 401(10371): 141-153, 2023 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36535295
3.
Modafinil for Severe Fatigue in Inflammatory Bowel Disease: A Prospective Case Series.
Clin Gastroenterol Hepatol
; 2024 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38191015
4.
Patterns of pharmacotherapy for bipolar disorder: A GBC survey.
Bipolar Disord
; 26(1): 22-32, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37463846
5.
Efficacy and safety of established and off-label ADHD drug therapies for cognitive impairment or attention-deficit hyperactivity disorder symptoms in bipolar disorder: A systematic review by the ISBD Targeting Cognition Task Force.
Bipolar Disord
; 26(3): 216-239, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38433530
6.
Aticaprant: (a κ-opioid receptor antagonist) for major depressive disorder.
Expert Opin Emerg Drugs
; : 1-12, 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38682267
7.
Ketamine cystitis following ketamine therapy for treatment-resistant depression - case report.
BMC Psychiatry
; 24(1): 9, 2024 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38166893
8.
Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: II. Sensitivity to treatment effects.
Aust N Z J Psychiatry
; 58(3): 250-259, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37927051
9.
Olanzapine for young PEople with aNorexia nervosa (OPEN): A protocol for an open-label feasibility study.
Eur Eat Disord Rev
; 32(3): 532-546, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38299859
10.
Is there a 'bipolar iceberg' in UK primary care psychological therapy services?
Psychol Med
; 53(12): 5385-5394, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35920607
11.
Does cognitive improvement translate into functional changes? Exploring the transfer mechanisms of cognitive remediation therapy for euthymic people with bipolar disorder.
Psychol Med
; 53(3): 936-944, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34140055
12.
The effect of a low-calorie diet on depressive symptoms in individuals with overweight or obesity: a systematic review and meta-analysis of interventional studies.
Psychol Med
; : 1-13, 2023 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38084632
13.
Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: I. Association with change in quality of life.
Psychol Med
; : 1-13, 2023 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36601813
14.
Self-blame in major depression: a randomised pilot trial comparing fMRI neurofeedback with self-guided psychological strategies.
Psychol Med
; 53(7): 2831-2841, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34852855
15.
Chronic post-COVID-19 syndrome and chronic fatigue syndrome: Is there a role for extracorporeal apheresis?
Mol Psychiatry
; 27(1): 34-37, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34140635
16.
A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials.
Mol Psychiatry
; 27(3): 1286-1299, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34907394
17.
Child and adolescent anxiety as a risk factor for bipolar disorder: A systematic review of longitudinal studies.
Bipolar Disord
; 25(4): 278-288, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36949612
18.
Associations between peripheral inflammation and clinical phenotypes of bipolar depression in a lower-middle income country.
CNS Spectr
; 28(6): 710-718, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37160707
19.
Cognitive Remediation in Bipolar (CRiB2): study protocol for a randomised controlled trial assessing efficacy and mechanisms of cognitive remediation therapy compared to treatment as usual.
BMC Psychiatry
; 23(1): 842, 2023 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37968619
20.
AI-based dimensional neuroimaging system for characterizing heterogeneity in brain structure and function in major depressive disorder: COORDINATE-MDD consortium design and rationale.
BMC Psychiatry
; 23(1): 59, 2023 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36690972